Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

30,221

Earnings per share:

Basic 0.69 0.76 0.11 1.36 1.66 0.24

Diluted 0.67 0.74 0.11 1.31 1.62 0.24

Earnings per ADS:

Basic 1.39 1.52 0.22 2.73 3.32 0.48

Diluted 1.34 1.48 0.22 2.63 3.23 0.47

Simcere Pharmaceutical Group

UNAUDITED CONSOLIDATED CONDENSED Balance Sheets

(Amounts expressed IN THOUSANDS)

December 31, June 30, June 30,

2007 2008 2008

RMB RMB USD

Assets

Current assets

Cash and cash equivalents

(including pledged bank

deposits) 498,262 339,047 49,431

Short term investments 470,000 610,000 88,933

Accounts and bills receivables,

net of allowance for doubtful

accounts 488,374 624,903 91,106

Inventories 65,241 85,311 12,438

Other current assets 35,276 79,982 11,661

Total current assets 1,557,153 1,739,243 253,569

Property, plant and equipment,

less accumulated depreciation 374,058 404,403 58,959

Land use rights 116,386 115,850 16,890

Intangible assets, net 251,221 296,417 43,215

Goodwill 161,496 187,902 27,395

Other assets 11,894 10,712 1,559

Total assets 2,472,208 2,754,527 401,587

Liabilities

Current liabilities


'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... which is currently going on in Chicago at Grant Park. The festival ... every corner of North America to Chicago for the annual Lollapalooza. This unique ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
(Date:7/31/2015)... ... , ... The 2nd annual Ride to Fight On will start and end ... The Ride to Fight On is a cycling fundraiser that benefits the West Cancer ... and The University of Tennessee Health Science Center. A health and wellness festival featuring ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... There’s ... as possible, even when it comes time to cook the next meal, making July ... of July by practicing best grilling tips and recipes. , Make the next cookout ...
(Date:7/31/2015)... ... 31, 2015 , ... Facebook, Twitter, Linkedin and blogs are ... media profiles to better connect with the public. The agency website at ... insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ways ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... EAST LANSING, Mich. Scientists at Michigan State University ... that trigger inflammation in the mammary gland. ... increasing the risk of breast cancer. Progesterone is ... the normal mammary gland. Progesterone previously has been identified ...
... 19, 2009) Scientists from the U.S. Department of ... Chicago,s Brain Tumor Center have developed a way to ... nanoparticles bonded to soft biological material. Thousands of ... the tumors are resistant to conventional therapies. This nano-bio ...
... , , TAMPA, Fla., Aug. ... People for the Ethical Treatment of Animals (PETA) to immediately end ... image and portrayal of obese/overweight individuals. The OAC believes this campaign ... their size or weight. , , The campaign ...
... , WASHINGTON, Aug. 19 Following ... , , The "Bulletin," which is free of ... you the latest issues and news affecting people with disabilities. To ... on "Online mailing list archives," select "NCD-NEWS-L," click on "Join or ...
... ... part of the new series of standard hybrid stepper motors presented by NMB. These popular ... ... announced today the availability of a new line of standard hybrid stepper motors. , , ...
... , , PACE(R) Programs Open Doors ... WASHINGTON, Aug. 19 In celebration of National Senior ... working with many of the individual Programs of All-inclusive Care for ... about PACE through health fairs and open houses. Designed to ...
Cached Medicine News:Health News:MSU scientists: Progesterone leads to inflammation 2Health News:Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials 2Health News:Obesity Action Coalition Calls on PETA to Immediately End Campaign Stigmatizing Overweight and Obese Individuals 2Health News:National Council on Disability Monthly Bulletin for August 2009 2Health News:National Council on Disability Monthly Bulletin for August 2009 3Health News:National Council on Disability Monthly Bulletin for August 2009 4Health News:National Council on Disability Monthly Bulletin for August 2009 5Health News:National Council on Disability Monthly Bulletin for August 2009 6Health News:National Council on Disability Monthly Bulletin for August 2009 7Health News:NMB's New Series of Standard Hybrid Stepper Motors Now Available 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 3
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today announced that Robert ... Directors. "Bob is an ardent champion for innovation ... privilege to have him on Edwards, board as we pursue ... Edwards, chairman and CEO.  "Bob has provided a valuable perspective ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... On March 11, 2011, the United States District ... as to a portion of the patent litigation brought ... and its wholly-owned subsidiary CIMA Labs, Inc., ("CIMA") against ... Inc., (collectively "Watson") pertaining to Cephalon,s FENTORA® fentanyl buccal ...
... 2011 SCOLR Pharma, Inc. (OTC Bulletin Board: ... letter from the Food and Drug Administration (FDA) identifying ... extended-release pseudoephedrine.   The Company said the ... had with the conduct of the bioequivalence study submitted ...
Cached Medicine Technology:Court Rules on First Set of Patents in FENTORA Litigation 2SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application 2
... Helmer Platelet Agitators feature ... with non-slip texture coating ... circulation for your platelets. ... to be used in ...
... Helmer platelet agitators offer a wide range ... allow the drawer storage platform to agitate ... which wear down and squeak. Sturdy, one-piece ... uniform air circulation for your platelets., ,i.Series ...
Platelet agitator....
EIA Kit for the detection of progesterone....
Medicine Products: